Cargando…
A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells
CD147, a type I transmembrane glycoprotein, is highly expressed in various cancer types and plays important roles in tumor progression, especially by promoting the motility and invasion of hepatocellular carcinoma (HCC) cells. These crucial roles make CD147 an attractive target for therapeutic inter...
Autores principales: | Fu, Zhi-guang, Wang, Li, Cui, Hong-yong, Peng, Jian-long, Wang, Shi-jie, Geng, Jie-jie, Liu, Ji-de, Feng, Fei, Song, Fei, Li, Ling, Zhu, Ping, Jiang, Jian-li, Chen, Zhi-nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891050/ https://www.ncbi.nlm.nih.gov/pubmed/26882566 http://dx.doi.org/10.18632/oncotarget.6990 |
Ejemplares similares
-
CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma
por: Wang, Shi-Jie, et al.
Publicado: (2020) -
CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells
por: Wang, Shi-Jie, et al.
Publicado: (2014) -
CD147 promotes cell motility via upregulation of p190-B RhoGAP in hepatocellular carcinoma
por: Chen, Ruo, et al.
Publicado: (2016) -
CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling
por: Cui, Hong-Yong, et al.
Publicado: (2015) -
Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy
por: Wu, Bo, et al.
Publicado: (2017)